Results 181 to 190 of about 4,859 (213)

Impulsivity, Psychological Distress, and Quality of Life Among the Patients With Acne Vulgaris: Factors Related to Acne Scars

Journal of Cosmetic Dermatology, Volume 25, Issue 4, April 2026.
ABSTRACT Background Acne scars affect up to 95% of acne vulgaris (AV) patients. However, there is little clinical data to predict which patients are more prone to create scars. Objective In this study, we aimed to evaluate the impulsivity, psychological distress, and quality of life in acne patients and factors related to acne scars. Methods This study
Halil İbrahim Yanik, Ersoy Acer, İmran Gökçen Yilmaz Karaman, Esra Ağaoğlu, Hilal Kaya Erdoğan, Muzaffer Bilgin, Zeynep Nurhan Saraçoğlu   +6 more
wiley   +1 more source

Skin care knowledge, attitudes and practices: a comparative study between patients with atopic dermatitis and healthy individuals. [PDF]

BMC Public Health
Wang D, Pan X, Wang J.
europepmc   +1 more source

Comparative Efficacy and Safety of Fractional CO2 Laser and Gold Microneedling Radiofrequency for Atrophic Acne Scars: A Systematic Review

Skin Research and Technology, Volume 32, Issue 4, April 2026.
ABSTRACT Background Acne is a prevalent dermatological disorder that profoundly affects patients' quality of life, frequently resulting in both physical discomfort and psychological distress. Conventional treatments, including topical agents, oral medications, and chemical peels, are primarily designed to alleviate symptoms but may be insufficient in ...
Xiaoyan Xiang, Weilong Shuai, Yunzhu Mu
wiley   +1 more source

A Novel Topical Emollient Plus for Canine Atopic Dermatitis: A Clinical Trial Assessing Efficacy and User Acceptance

Veterinary Dermatology, Volume 37, Issue 2, Page 293-305, April 2026.
Background: Canine atopic dermatitis (cAD) is a common, chronic skin condition characterised by epidermal barrier dysfunction, immune dysregulation and cutaneous dysbiosis. While “emollient plus” formulations are widely used in human atopic dermatitis, their role in cAD remains underexplored. Hypothesis/Objectives: To evaluate the clinical efficacy and
Beatriz Fernandes, António Caldeira Mendes, Susana Paula Alves, Vanessa Schmidt, Ana Filipa Bizarro, Marta Pinto, Hugo Pereira, Joana Marto, Ana Mafalda Lourenço   +8 more
wiley   +1 more source

Secretome as a novel regenerative strategy for atopic dermatitis: a comprehensive review. [PDF]

Stem Cell Res Ther
Subramaniam P, Shafiee MN, Fadilah NIM, Fauzi MB, Maarof M.   +4 more
europepmc   +1 more source

Simple and Scalable Electrochemical Reduction of Alkyl Oxalates Using Carbon‐Based Electrodes

ChemSusChem, Volume 19, Issue 6, 27 March 2026.
A method for the electrochemical reduction of alkyl oxalates under mild and ambient conditions in a very simple two‐electrode undivided setup under galvanostatic conditions is established. A simple isolation by direct distillation of the crude mixture in combination with the reusability of the electrodes provides all prerequisites for potential ...
Sebastian Kissel, Philipp Schnieders, Volker Derdau, Siegfried R. Waldvogel   +3 more
wiley   +1 more source

Reframing Eczema: Th2-Skewed Contact Sensitization, Atopy Patch Testing, and Systemic Contact Dermatitis. [PDF]

Curr Allergy Asthma Rep
Jacob SE, Scheman A, Nedorost S.
europepmc   +1 more source

Viscoelastic Behaviors of Hyaluronic Derivatives as a Function of pH, Salt, and Temperature

Journal of Polymer Science, Volume 64, Issue 6, Page 1505-1517, 15 March 2026.
Viscoelastic properties of hyaluronic acid grafted with polyether side‐chains (HA‐PEPO) can be controlled in aqueous media over more than three decades of amplitude with the possibility to get liquid or gel states, regardless of temperature, as well as sol/gel transitions induced by cooling or heating by the interplay between hydrogen bonds ...
Yogesh Kadam, Manohar V. Badiger, Pattuparambil R. Rajamohanan, Prakash P. Wadgaonkar, Guylaine Ducouret, Theo Merland, Dominique Hourdet   +6 more
wiley   +1 more source

Case Report: Zinc deficiency as a modifiable risk factor for enfortumab vedotin-induced cutaneous adverse events. [PDF]

Front Oncol
Nishizawa A, Itoh M, Inoue M, Makiguchi M, Koga F.   +4 more
europepmc   +1 more source